1.38
price up icon0.00%   0.00
after-market Handel nachbörslich: 8.73 7.35 +532.61%
loading
Schlusskurs vom Vortag:
$1.38
Offen:
$1.36
24-Stunden-Volumen:
46,429
Relative Volume:
0.20
Marktkapitalisierung:
$41.81M
Einnahmen:
$144.81M
Nettoeinkommen (Verlust:
$-28.66M
KGV:
-1.474
EPS:
-0.9362
Netto-Cashflow:
$-7.67M
1W Leistung:
-4.83%
1M Leistung:
-6.76%
6M Leistung:
-37.41%
1J Leistung:
-82.71%
1-Tages-Spanne:
Value
$1.35
$1.41
1-Wochen-Bereich:
Value
$1.35
$1.52
52-Wochen-Spanne:
Value
$1.23
$9.42

Zynex Inc Stock (ZYXI) Company Profile

Name
Firmenname
Zynex Inc
Name
Telefon
(800)-495-6670
Name
Adresse
9655 MAROON CIRCLE, ENGLEWOOD, CO
Name
Mitarbeiter
1,000
Name
Twitter
@zynexmedical
Name
Nächster Verdiensttermin
2025-03-11
Name
Neueste SEC-Einreichungen
Name
ZYXI's Discussions on Twitter

Vergleichen Sie ZYXI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
9.30 0 0 0 0 0.00
 icon
MOBBW
Mobilicom Limited Warrants
4.07 5.67B 0 0 0 0.00
 icon
GOODO
Gladstone Commercial Corporation
20.22 372.90M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
3.13 109.81M 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.195 429.79M 2.07B -1.42B -1.37B -0.6765
 icon
DAVEW
Dave Inc
1.08 0 0 0 0 0.00

Zynex Inc Stock (ZYXI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-01 Herabstufung H.C. Wainwright Buy → Neutral
2025-08-01 Hochstufung Ladenburg Thalmann Neutral → Buy
2025-03-12 Herabstufung Ladenburg Thalmann Buy → Neutral
2025-03-12 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2023-10-16 Eingeleitet RBC Capital Mkts Outperform
2023-01-06 Hochstufung Piper Sandler Neutral → Overweight
2022-02-28 Bestätigt B. Riley Securities Buy
2021-07-16 Hochstufung B. Riley Securities Neutral → Buy
2021-03-09 Hochstufung Northland Capital Market Perform → Outperform
2021-02-26 Herabstufung B. Riley Securities Buy → Neutral
2021-01-29 Herabstufung Piper Sandler Overweight → Neutral
2021-01-28 Herabstufung Northland Capital Outperform → Market Perform
2020-09-14 Hochstufung H.C. Wainwright Neutral → Buy
2020-09-09 Hochstufung Northland Capital Market Perform → Outperform
2020-07-29 Hochstufung B. Riley FBR Neutral → Buy
2020-07-20 Eingeleitet Piper Sandler Overweight
2020-07-13 Herabstufung B. Riley FBR Buy → Neutral
2020-07-10 Bestätigt H.C. Wainwright Neutral
2020-06-16 Herabstufung Northland Capital Outperform → Market Perform
2020-05-19 Herabstufung H.C. Wainwright Buy → Neutral
2020-04-01 Eingeleitet Northland Capital Outperform
2019-09-23 Eingeleitet H.C. Wainwright Buy
Alle ansehen

Zynex Inc Aktie (ZYXI) Neueste Nachrichten

pulisher
Oct 14, 2025

Will Zynex Inc. stock rally after Fed decisionsMarket Performance Summary & Safe Entry Trade Signal Reports - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Pattern recognition hints at Zynex Inc. upside2025 Technical Overview & Free Risk Controlled Daily Trade Plans - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Technical signs of recovery in Zynex Inc.Weekly Market Report & Precise Entry and Exit Recommendations - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

Can Zynex Inc. stock deliver surprise earnings beatWeekly Stock Recap & Low Drawdown Momentum Ideas - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

What institutional flow reveals about Zynex Inc.2025 Geopolitical Influence & Real-Time Chart Pattern Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Reversal indicators forming on Zynex Inc. stockEarnings Summary Report & Free Community Consensus Stock Picks - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

What machine learning models say about Zynex Inc.Portfolio Gains Report & Community Driven Trade Alerts - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zynex, Inc. (ZYXI) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Oct 12, 2025
pulisher
Oct 09, 2025

2025-10-09 | Zynex, Inc. (ZYXI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NDAQ:ZYXI | Press Release - Stockhouse

Oct 09, 2025
pulisher
Oct 09, 2025

Visual trend scoring systems applied to Zynex Inc.Quarterly Portfolio Review & High Return Trade Guides - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Colorado medtech company laying off more of its employees - The Business Journals

Oct 08, 2025
pulisher
Oct 07, 2025

Zynex Seeks Partner for NiCO CO-Oximeter Commercialization - TipRanks

Oct 07, 2025
pulisher
Oct 07, 2025

Zynex announces workforce reduction and $31 million asset impairment at subsidiary - Investing.com

Oct 07, 2025
pulisher
Oct 07, 2025

Zynex terminated positions of a majority of ZMS employees - MarketScreener

Oct 07, 2025
pulisher
Oct 06, 2025

Is this a good reentry point in Zynex Inc.Market Performance Recap & Fast Exit and Entry Strategy Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Using flow based indicators on Zynex Inc.July 2025 Drop Watch & Expert Curated Trade Setup Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Zynex, Inc. (ZYXI) And Encourages Investors to Connect - ACCESS Newswire

Oct 05, 2025
pulisher
Oct 05, 2025

Zynex Inc. stock chart pattern explainedQuarterly Portfolio Summary & Long-Term Safe Investment Plans - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

What MACD and RSI say about Zynex Inc.2025 Growth vs Value & Long-Term Growth Stock Strategies - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Zynex Investors Seek To Merge, Stay Insider Trading Suits - Law360

Oct 03, 2025
pulisher
Oct 01, 2025

Is Zynex Inc. stock attractive for long term wealth buildingEarnings Beat & Stock Portfolio Risk Control - newser.com

Oct 01, 2025
pulisher
Sep 30, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zynex, Inc. (ZYXI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Sep 30, 2025
pulisher
Sep 30, 2025

2025-09-30 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zynex, Inc. (ZYXI) and Encourages Investors to Learn More About the Investigation | NDAQ:ZYXI | Press Release - Stockhouse

Sep 30, 2025
pulisher
Sep 29, 2025

Zynex (NASDAQ:ZYXI) versus Insulet (NASDAQ:PODD) Head to Head Review - Defense World

Sep 29, 2025
pulisher
Sep 28, 2025

What drives Zynex Inc stock priceStock Watchlist Updates & Low Risk Portfolio Growth - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

Zynex, Inc. (ZYXI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Sep 28, 2025
pulisher
Sep 28, 2025

What analysts say about Zynex Inc stockMarket Liquidity Analysis & Free Webinars On Market Trends - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

2025-09-28 | Zynex, Inc. (ZYXI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:ZYXI | Press Release - Stockhouse

Sep 28, 2025
pulisher
Sep 28, 2025

ZYNEX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire

Sep 28, 2025
pulisher
Sep 27, 2025

ZYNEX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.

Sep 27, 2025
pulisher
Sep 23, 2025

Zynex Appoints Anna Lucsok as Chief Commercial Officer - The Globe and Mail

Sep 23, 2025
pulisher
Sep 22, 2025

Zynex shifts Anna Lucsok from COO to chief commercial officer By Investing.com - Investing.com Australia

Sep 22, 2025

Finanzdaten der Zynex Inc-Aktie (ZYXI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Zynex Inc-Aktie (ZYXI) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
MOORHEAD DANIEL J
CHIEF FINANCIAL OFFICER
Feb 03 '25
Sale
7.68
10,000
76,800
19,738
$1.095
price up icon 7.35%
$2.14
price up icon 2.39%
$2.52
price up icon 3.70%
medical_distribution OMI
$4.58
price down icon 0.22%
medical_distribution AHG
$1.66
price down icon 2.92%
Kapitalisierung:     |  Volumen (24h):